3649 results for «324»
3649 results
New evidence for coronary physiology in epicardial disease
20 May 2026 – From EuroPCR 2026
Explore new evidence in coronary physiology related to epicardial disease through analyses of landmark trials and registries. Topics include five-year follow-up data from DEFINE-FLAIR and iFR-SWEDEHEART, complete revascularization in elderly myocardial infarction patients, angiography-derived versus pressure wire assessments, prognostic implications of CT angiography-derived physiology, and the...
Left main PCI: technical limits
21 May 2026 – From EuroPCR 2026
This comprehensive session reviews the technical challenges and current strategies in left main PCI. Topics include provisional versus DK crush approaches, IVUS-based assessment of ostial LAD lesions, long-term outcomes of DCB use in left main bifurcations, stenting strategies for complex lesions, and the prognostic value of...
Ambiguous left main lesions: how to assess severity and make the right decision
21 May 2026 – From EuroPCR 2026
Addressing the complexities of ambiguous left main coronary lesions, this session elucidates the integration of physiology, intracoronary imaging, and CT scanning for comprehensive assessment. It highlights multimodality diagnostic strategies and decision-making frameworks to guide appropriate revascularization.
Imaging-guided strategy for understanding coronary calcification
21 May 2026 – From EuroPCR 2026
Focusing on coronary calcification, this session teaches the application of CT and intracoronary imaging to characterize calcium patterns, select appropriate modification tools, and assess procedural success. It emphasizes imaging-guided strategies to optimize treatment of calcified coronary lesions.
Identifying and planning protected temporary mechanical circulatory support-based procedures in high-risk patients
21 May 2026 – From EuroPCR 2026
This session provides an in-depth update on protected temporary mechanical circulatory support-based procedures in high-risk cardiac patients. It covers patient identification criteria, device selection, and multidisciplinary planning to optimize outcomes in protected PCI, ventricular ablation, and surgical contexts.
The pearl of unloading with mechanical circulatory support
21 May 2026 – From EuroPCR 2026
Delve into the critical aspects of mechanical circulatory support in cardiogenic shock, focusing on device selection, assessment of persistent congestion, and the application of unloading tools to improve patient management and outcomes.
Combined mitral repair and LAA closure with two separate septal punctures - LIVE case
21 May 2026 – From EuroPCR 2026
A 79‑year‑old man with hypertension, a history of basal cell carcinoma and psoriasis, presented with symptomatic severe primary MR (flail P2 due to ruptured chordae) and bleeding complications (recurrent skin bleeding) while on DOAC therapy for permanent atrial fibrillation.
Two G5 MitraClip devices were implanted. Subsequently, through...
Spectrum of cardiogenic shock
21 May 2026 – From EuroPCR 2026
This session delves into the broad spectrum of cardiogenic shock phenotypes, emphasizing the importance of selecting appropriate left ventricular support tailored to specific clinical scenarios. It offers critical insights into the timing of mechanical circulatory support and revascularisation strategies to optimize patient outcomes.
Calcified lesion of distal protected left main - LIVE case
22 May 2026 – From EuroPCR 2026
An 85‑year‑old man with type 2 diabetes mellitus, hypertension, dyslipidemia, peripheral artery disease, COPD, and chronic kidney disease presented with CCS class II angina related to three‑vessel coronary artery disease. He had previously undergone hybrid revascularization, including PCI of the RCA ostium and CABG with LIMA...
Multivessel complications: what can go wrong
21 May 2026 – From EuroPCR 2026
This session highlights complications encountered in multivessel coronary interventions, presenting complex cases such as lost stents, coronary perforations, shaft fractures, early subacute stent thrombosis, and rare triple vessel thrombosis. It emphasizes practical management strategies for these challenging scenarios in contemporary interventional cardiology.
New data on intracoronary imaging-guided interventions
21 May 2026 – From EuroPCR 2026
This session presents new data on intracoronary imaging-guided interventions, comparing outcomes of angiography-derived FFR and IVUS-guided PCI over two years, as well as OCT versus IVUS for intermediate left main stenosis. It further evaluates high-risk non-culprit lesions post-myocardial infarction, the role of coronary lipid burden in...
All you need to know of DAPT in ACS
21 May 2026 – From EuroPCR 2026
This session provides an in-depth review of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS), focusing on strategies for safe de-escalation and P2Y12 inhibitor monotherapy to reduce bleeding risk without compromising ischemic protection. It also covers optimizing antithrombotic therapy in patients on oral anticoagulation and...
New evidence in coronary physiology for microvascular assessment
21 May 2026 – From EuroPCR 2026
This session highlights new evidence in coronary physiology related to microvascular assessment. Topics include endothelial dysfunction in angina with non-obstructive arteries, the prognostic value of microvascular resistance metrics, natural history studies, and trials aimed at standardizing management of microvascular dysfunction.
Simplify the complex with Shockwave C2 Aero - Next-generation coronary intravascular lithotripsy that delivers
21 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session highlights the role of the next-generation Shockwave C2 Aero coronary intravascular lithotripsy system in the treatment of complex calcified coronary artery disease. Supported by real-world clinical experience and recent evidence, the discussion focuses on procedural safety, lesion preparation, and treatment consistency in...
Left main and complex bifurcation stenting
21 May 2026 – From EuroPCR 2026
This focused session explores optimal strategies for treating left main and complex bifurcation coronary lesions, a setting that remains both anatomically and technically demanding.
It highlights the role of intracoronary imaging in refining procedural planning and optimising stenting strategy and technique. The discussion also reviews the mechanical...
The right therapy for right heart failure and tricuspid regurgitation: fixing my patient congestion, not just a valve
21 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session shifts the focus in tricuspid regurgitation from anatomy alone to the broader context of right heart failure and systemic congestion. It highlights the limitations of purely leaflet-based strategies, particularly in advanced disease and in the presence of severe right ventricular dysfunction.
The discussion...
Aortic regurgitation in 2026
21 May 2026 – From EuroPCR 2026
Get a comprehensive overview of contemporary management strategies for aortic regurgitation, a condition that remains frequently underdiagnosed and undertreated despite significant advances in transcatheter therapies thanks to this EuroPCR 2026 session.
The programme reviews current diagnostic and treatment pathways, including guideline-based management and the role of surgical...
LDL-C management: should it begin in the cathlab?
21 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session examines the evolving role of LDL cholesterol management in patients undergoing percutaneous coronary intervention (PCI), with a focus on the potential benefits of initiating intensive lipid-lowering strategies early in the patient pathway.
The discussion reviews emerging evidence on PCSK9 inhibition in elective PCI...
Active unloading with Impella heart pumps in elective and emergent patients
21 May 2026 – From EuroPCR 2026
This session presents the latest evidence on the use of microaxial Impella heart pumps in both elective high-risk and emergent cardiogenic shock patients. It highlights the importance of organised systems of care in improving survival outcomes and explores current data and expert consensus on mechanical circulatory...
DCB: does coating morphology matter for distal embolisation and clinical outcomes?
20 May 2026 – From EuroPCR 2026
Drug-coated balloon (DCB) therapy continues to evolve, with increasing attention on how coating design may influence drug transfer, vessel response and downstream clinical outcomes.
This EuroPCR 2026 session examines the role of coating morphology, comparing amorphous and crystalline technologies and their implications for drug delivery efficiency and...
